Skip to main content
Premium Trial:

Request an Annual Quote

454 to Expand Manufacturing Space

Premium

Roche's 454 Life Sciences is expanding into new manufacturing space, a company official told In Sequence last month.

The official did not provide any further details about the expansion, but according to a report in the Hartford Courant, 454 plans to invest $5 million into a 55,400-square-foot industrial building in Branford, Conn., its current location, "to outfit it for research and development." The newspaper cited commercial real estate brokers as its source.

The expansion plans coincide with 454's announcement late last year that it plans to launch a new sequencing instrument, called GS Junior, in the spring or early summer (see In Sequence 12/1/2009).

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.